Chemoinformaics analysis of Bis-gamma-glutamylcystine
| Molecular Weight | 498.536 | nRot | 17 |
| Heavy Atom Molecular Weight | 472.328 | nRig | 6 |
| Exact Molecular Weight | 498.109 | nRing | 0 |
| Solubility: LogS | -1.864 | nHRing | 0 |
| Solubility: LogP | -5.374 | No. of Aliphatic Rings | 0 |
| Acid Count | 4 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 62.2766 |
| nHD | 8 | BPOL | 33.7514 |
| QED | 0.079 |
| Synth | 3.775 |
| Natural Product Likeliness | 0.357 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.531 |
| HIA | 0.699 |
| CACO-2 | -6.82 |
| MDCK | 0.000914416 |
| BBB | 0.063 |
| PPB | 0.141685 |
| VDSS | 0.777 |
| FU | 0.662226 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.001 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.015 |
| CYP2c9-inh | 0.226 |
| CYP2c9-sub | 0.257 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.072 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0 |
| CL | 2.182 |
| T12 | 0.801 |
| hERG | 0.005 |
| Ames | 0.028 |
| ROA | 0.002 |
| SkinSen | 0.324 |
| Carcinogencity | 0.023 |
| EI | 0.083 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.019 |
| Antiviral | Yes |
| Prediction | 0.739742 |